360 High-Risk Vulnerability Immunization Tool V2.0 vs DefenseArk Brightscan: Side-by-Side Comparison (2026)

360 High-Risk Vulnerability Immunization Tool V2.0: Tool that immunizes Windows systems against critical vulnerabilities. built by 360 Security Group (Qihoo 360). Core capabilities include Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation..

DefenseArk Brightscan: AI-powered distributed antivirus platform for Windows home & business users. built by DefenseArk (OpenAVN). Core capabilities include AI-powered malware scanning, Crowdsourced threat intelligence via global network of digital threat detectors, Rapid virus definition updates (3–5 days from detection to inoculation)..

Both serve the Endpoint Protection Platform market but differ in approach, feature depth, and target audience.

360 High-Risk Vulnerability Immunization Tool V2.0 differentiates with Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation. DefenseArk Brightscan differentiates with AI-powered malware scanning, Crowdsourced threat intelligence via global network of digital threat detectors, Rapid virus definition updates (3–5 days from detection to inoculation).

360 High-Risk Vulnerability Immunization Tool V2.0 is developed by 360 Security Group (Qihoo 360). DefenseArk Brightscan is developed by DefenseArk (OpenAVN). Vendor maturity, funding stage, and team size can be important factors when evaluating long-term viability and support quality.

360 High-Risk Vulnerability Immunization Tool V2.0 and DefenseArk Brightscan serve similar Endpoint Protection Platform use cases: both are Endpoint Protection Platform tools. Review the feature comparison above to determine which fits your requirements.